CONMED Corporation (CNMD) is a publicly traded Healthcare sector company. As of August 25, 2026, CNMD trades at $51.14 with a market cap of $1.54B and a P/E ratio of 27.54. CNMD moved -0.70% today. Year to date, CNMD is +26.18%; over the trailing twelve months it is -5.80%. Its 52-week range spans $31.44 to $74.70. Analyst consensus is neutral with an average price target of $45.25. Rallies surfaces CNMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CNMD insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $51.14 |
| Market Cap | $1.54B |
| P/E Ratio | 27.54 |
| EPS | $1.85 |
| Dividend Yield | 0.20% |
| 52-Week High | $74.70 |
| 52-Week Low | $31.44 |
| Volume | 164.63K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.37B |
| Net Income | $56.50M |
| Gross Margin | 55.79% |
6 analysts cover CNMD: 0 strong buy, 0 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $45.25.